公開日期 | 標題 | 作者 | 來源出版物 | scopus | WOS | 全文 |
2022 | Identification and analysis of a selective DYRK1A inhibitor | Lin T.E.; Chao M.-W.; HuangFu W.-C.; Tu H.-J.; Peng Z.-X.; Su C.-J.; Sung T.-Y.; Hsieh J.-H.; Lee C.-C.; CHIA-RON YANG ; Pan S.-L.; Hsu K.-C. | Biomedicine and Pharmacotherapy | 6 | 3 | |
2021 | Identification of a dual TAOK1 and MAP4K5 inhibitor using a structure-based virtual screening approach | Chao M.-W.; Lin T.E.; HuangFu W.-C.; Chang C.-D.; Tu H.-J.; Chen L.-C.; Yen S.-C.; Sung T.-Y.; Huang W.-J.; CHIA-RON YANG ; Pan S.-L.; Hsu K.-C. | Journal of Enzyme Inhibition and Medicinal Chemistry | 9 | 8 | |
2014 | Indole-3-ethylsulfamoylphenylacrylamides: Potent histone deacetylase inhibitors with anti-inflammatory activity | Mehndiratta S.; Hsieh Y.-L.; Liu Y.-M.; Wang A.W.; Lee H.-Y.; Liang L.-Y.; Kumar S.; Teng C.-M.; CHIA-RON YANG ; Liou J.-P. | European Journal of Medicinal Chemistry | 41 | 39 | |
2007 | Inhibition of neuronal migration by JONES antibody is independent of 9-O-acetyl GD3 in GD3-synthase knockout mice | CHIA-RON YANG ; Liour S.S.; Dasgupta S.; Yu R.K. | Journal of Neuroscience Research | 11 | 10 | |
2013 | Inside Cover: 1-Arylsulfonyl-5-(N-hydroxyacrylamide)indolines Histone Deacetylase Inhibitors Are Potent Cytokine Release Suppressors (ChemBioChem 10/2013) | Lee H.-Y.; CHIA-RON YANG ; Lai M.-J.; Huang H.-L.; Hsieh Y.-L.; Liu Y.-M.; Yeh T.-K.; Li Y.-H.; Mehndiratta S.; Teng C.-M.; Liou J.-P. | ChemBioChem | 0 | 0 | |
2009 | Intracerebral transplantation of neural stem cells combined with trehalose ingestion alleviates pathology in a mouse model of Huntington's disease | CHIA-RON YANG ; Yu R.K. | Journal of Neuroscience Research | 45 | 38 | |
2019 | Moscatilin Ameliorates Tau Phosphorylation and Cognitive Deficits in Alzheimer's Disease Models | Huang J.-M.; Huang F.-I.; CHIA-RON YANG | Journal of Natural Products | 18 | 18 | |
2019 | MPT0G413, A novel HDAC6-selective inhibitor, and bortezomib synergistically exert anti-tumor activity in multiple myeloma cells | Huang F.-I.; Wu Y.-W.; Sung T.-Y.; Liou J.-P.; Lin M.-H.; Pan S.-L.; CHIA-RON YANG | Frontiers in Oncology | 19 | 18 | |
2018 | (N-Hydroxycarbonylbenylamino)quinolines as Selective Histone Deacetylase 6 Inhibitors Suppress Growth of Multiple Myeloma in Vitro and in Vivo | Lee H.-Y.; Nepali K.; Huang F.-I.; Chang C.-Y.; Lai M.-J.; Li Y.-H.; Huang H.-L.; CHIA-RON YANG ; Liou J.-P. | Journal of Medicinal Chemistry | 63 | 60 | |
2021 | Neuroprotective studies of evodiamine in an okadaic acid-induced neurotoxicity | Chou C.-H.; CHIA-RON YANG | International Journal of Molecular Sciences | 18 | 15 | |
2021 | A novel dual HDAC and HSP90 inhibitor, MPT0G449, downregulates oncogenic pathways in human acute leukemia in vitro and in vivo | Wu Y.-W.; Chao M.-W.; Tu H.-J.; Chen L.-C.; Hsu K.-C.; Liou J.-P.; CHIA-RON YANG ; Yen S.-C.; HuangFu W.-C.; Pan S.-L. | Oncogenesis | 15 | 16 | |
2018 | The novel histone de acetylase 6 inhibitor, MPT0G211, ameliorates tau phosphorylation and cognitive deficits in an Alzheimer's disease model article | Fan S.-J.; Huang F.-I.; Liou J.-P.; CHIA-RON YANG | Cell Death and Disease | 66 | 64 | |
2016 | Novel histone deacetylase inhibitor MPT0G009 induces cell apoptosis and synergistic anticancer activity with tumor necrosis factor-related apoptosis-inducing ligand against human hepatocellular carcinoma | Chen M.-C.; Huang H.-H.; Lai C.-Y.; Lin Y.-J.; Liou J.-P.; Lai M.-J.; Li Y.-H.; Teng C.-M.; CHIA-RON YANG | Oncotarget | 20 | 20 | |
2022 | O-methylated flavonol as a multi-kinase inhibitor of leukemogenic kinases exhibits a potential treatment for acute myeloid leukemia | Yen S.-C.; Wu Y.-W.; Huang C.-C.; Chao M.-W.; Tu H.-J.; Chen L.-C.; Lin T.E.; Sung T.-Y.; Tseng H.-J.; Chu J.-C.; Huang W.-J.; CHIA-RON YANG ; HuangFu W.-C.; Pan S.-L.; Hsu K.-C. | Phytomedicine | 5 | 5 | |
2017 | An oral quinoline derivative, MPT0B392, causes leukemic cells mitotic arrest and overcomes drug resistant cancer cells | Chao M.-W.; Huang H.-L.; HuangFu W.-C.; Hsu K.-C.; Liu Y.-M.; Wu Y.-W.; Lin C.-F.; Chen Y.-L.; Lai M.-J.; Lee H.-Y.; Liou J.P.; Teng C.-M.; CHIA-RON YANG | Oncotarget | 6 | 5 | |
2011 | Potent anti-inflammatory effects of denbinobin mediated by dual inhibition of expression of inducible no synthase and cyclooxygenase 2 | Liu H.-E.; Chang A.S.-Y.; Teng C.-M.; Chen C.-C.; Tsai A.-C.; CHIA-RON YANG | Shock | 24 | 27 | |
2014 | Preclinical anti-arthritic study and pharmacokinetic properties of a potent histone deacetylase inhibitor MPT0G009 | Hsieh I.-N.; Liou J.-P.; Lee H.-Y.; Lai M.-J.; Li Y.-H.; CHIA-RON YANG | Cell Death and Disease | 30 | 29 | |
2004 | Soluble Decoy Receptor 3 Induces Angiogenesis by Neutralization of TL1A, a Cytokine Belonging to Tumor Necrosis Factor Superfamily and Exhibiting Angiostatic Action | CHIA-RON YANG ; Hsieh S.-L.; Teng C.-M.; Ho F.-M.; Su W.-L.; WAN-WAN LIN | Cancer Research | 103 | 94 | |
2022 | Structure-based virtual screening and biological evaluation of novel small-molecule BTK inhibitors | Lin T.E.; Sung L.-C.; Chao M.-W.; Li M.; Zheng J.-H.; Sung T.-Y.; Hsieh J.-H.; CHIA-RON YANG ; Lee H.-Y.; Cho E.-C.; Hsu K.-C. | Journal of Enzyme Inhibition and Medicinal Chemistry | 3 | 3 | |
2023 | The study of a novel CDK8 inhibitor E966-0530-45418 that inhibits prostate cancer metastasis in vitro and in vivo | Ho, Tai-Yuan; Sung, Ting-Yi; Pan, Shiow-Lin; Huang, Wei-Jan; Hsu, Kai-Cheng; Hsu, Jui-Yi; Lin, Tony Eight; Hsu, Chia-Ming; CHIA-RON YANG | Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie | 2 | 1 | |